VEGFA and neoplasm: Mutations of amino acid residues that coordinate Zn2+ lead to the decrease of endostatin anti-tumor activity [20], but not its anti-proliferative effect on endothelial cells, stimulated by vascular endothelial growth factor (VEGF) [21], or its anti-angiogenic activity in a model of angiogenesis induced by VEGF [19].